William D. McClellan Jr., Director at REATA PHARMACEUTICALS INC (RETA), sold 8,000 shares at $173.21 ($1.4M) on 2020-11-12, disclosed to the SEC on 2020-11-13.
Open-market sale of $1.4M RETA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $172.44 | 2,542 | $438K | 31.7% |
| 2 | $172.44 | 2,542 | $438K | 31.7% |
| 3 | $173.21 | 970 | $168K | 12.1% |
| 4 | $173.21 | 970 | $168K | 12.1% |
| 5 | $174.82 | 488 | $85K | 6.2% |
| 6 | $174.82 | 488 |
| $85K |
| 6.2% |
| Total | $172.92 avg | 8,000 | $1.4M | 100% |
| Filing → |
| APEN | BUY | 2017-05-30 | $13K | — | Filing → |
| APEN | BUY | 2017-05-18 | $11K | — | Filing → |